181 related articles for article (PubMed ID: 15525368)
1. Glycopeptide resistant Staphylococcus.
Witte W
J Vet Med B Infect Dis Vet Public Health; 2004; 51(8-9):370-3. PubMed ID: 15525368
[TBL] [Abstract][Full Text] [Related]
2. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC
Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
[TBL] [Abstract][Full Text] [Related]
3. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
Młynarczyk A; Młynarczyk G; Łuczak M
Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662
[TBL] [Abstract][Full Text] [Related]
4. [Conjugative transfer of glycopeptide and macrolide resistant genes among Enterococci and from Enterococcus faecalis to Staphylococcus aureus].
Młynarczyk A; Młynarczyk G; Łuczak M
Med Dosw Mikrobiol; 2002; 54(1):21-8. PubMed ID: 12185680
[TBL] [Abstract][Full Text] [Related]
5. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Appelbaum PC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
[TBL] [Abstract][Full Text] [Related]
6. [Detection methods for drug-resistant bacteria in routine examination--VISA].
Kinoshita S; Nakamachi Y
Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus.
Ruef C
Infection; 2004 Dec; 32(6):315-27. PubMed ID: 15597220
[TBL] [Abstract][Full Text] [Related]
8. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.
Garnier F; Chainier D; Walsh T; Karlsson A; Bolmström A; Grelaud C; Mounier M; Denis F; Ploy MC
J Antimicrob Chemother; 2006 Jan; 57(1):146-9. PubMed ID: 16286482
[TBL] [Abstract][Full Text] [Related]
9. [Methicillin resistant Staphylococcus].
Marin M
Medicina (B Aires); 2002; 62 Suppl 2():30-5. PubMed ID: 12481486
[TBL] [Abstract][Full Text] [Related]
10. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
11. The VISA/GISA problem: therapeutic implications.
Liñares J
Clin Microbiol Infect; 2001; 7 Suppl 4():8-15. PubMed ID: 11688538
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
McDonald LC; Hageman JC
Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin resistance in gram-positive cocci.
Courvalin P
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
Drummelsmith J; Winstall E; Bergeron MG; Poirier GG; Ouellette M
J Proteome Res; 2007 Dec; 6(12):4690-702. PubMed ID: 17997515
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides.
El Solh N; Davi M; Morvan A; Damon HA; Marty N;
J Antimicrob Chemother; 2003 Oct; 52(4):691-4. PubMed ID: 12951351
[TBL] [Abstract][Full Text] [Related]
17. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.
Whitener CJ; Park SY; Browne FA; Parent LJ; Julian K; Bozdogan B; Appelbaum PC; Chaitram J; Weigel LM; Jernigan J; McDougal LK; Tenover FC; Fridkin SK
Clin Infect Dis; 2004 Apr; 38(8):1049-55. PubMed ID: 15095205
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus.
Amiali NM; Mulvey MR; Berger-Bächi B; Sedman J; Simor AE; Ismail AA
J Antimicrob Chemother; 2008 Jan; 61(1):95-102. PubMed ID: 17962217
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
